The pleoitropic effect of inflammatory cytokines demands complex and multi faceted regulation to limit collateral damage to normal tissue. On one level, inflammatory cytokines such as inter leukin 1 (IL1) and IL18 exist as in active zymogens that require proteolytic cleavage mediated by the inflammasome (Martinon et al., 2008) . This proteolytic maturation acts in concert with NFB-dependent transcriptional activation of genes encoding the zymogens to catalyze a substantial increase in the levels of se creted, bioactive protein. Other inflam matory cytokines such as tumor necrosis factor (TNF) and IL6 are induced pri marily at the transcriptional level and, in the case of TNF, subject to posttranscrip tional messenger RNA stabilization by virtue of the dissociation of the mRNA binding protein tristetraprolin from its adenine and uridinerich (ARE) region (Anderson, 2000) . Although these are wellestablished mechanisms of regulat ing proinflammatory cytokine produc tion, it is becoming apparent that an additional layer of complexity exists; i.e., signals provided by ROS.
The mitochondrion plays a critical role in cell survival, most prominently by generating the vast majority of a cell's supply of adenosine triphosphate (ATP), but also by influencing apoptosis, cell cycle, and metabolism. Mitochondria generate ATP through aerobic respira tion, whereby glucose, pyruvate, and NADH are oxidized, thus generating ROS as a byproduct. In normal cir cumstances, the deleterious effects caused by the highly reactive nature of ROS are balanced by the presence of antioxidants, including glutathione, carotenoids, and antioxidant enzymes such as catalase and glutathione peroxi dase. However, several chronic human diseases associated with inflammation are also characterized by excessive ROS production (Drake et al., 1998; Cominelli, 2004; Reuter et al., 2010) . Perhaps not surprisingly, defective mi tochondria have also been implicated in human diseases with underlying in flammatory pathologies, such as diabe tes mellitus and cardiac dysfunction (DiMauro and Schon, 2003; Nisoli et al., 2007; Patti and Corvera, 2010) .
Three recent publications, includ ing Bulua et al. in this issue, indicate that mitochondrial ROS (mtROS) act as signaling molecules to trigger proinflammatory cytokine production (Nakahira et al., 2011; Zhou et al., 2011) . These observations provide much needed clarification about the cellular source of ROS that impacts the production of certain inflammatory cytokines. Although all three publica tions underscore the importance of mtROSdependent signaling, they dif fer most notably by describing either inflammasomedependent or inflam masomeindependent roles for ROS.
Using cells from patients with TNFR1associated periodic syndrome (TRAPS), along with a relevant mouse model, Bulua et al. (2011) demonstrate that mtROS influences the transcription of proinflammatory cytokines such as IL6. In its most severe form, TRAPS manifests as episodes of fever and severe localized inflammation that is associated with "structural" mutations in TNFR1. These TNFR1 mutations interfere with downregulation of cell surface TNFR expression, result in retention of the re ceptor within the endoplasmic reticu lum, confer ligand (TNF) independence, and prolong the cytokine response to lipopolysaccharide (LPS; McDermott et al., 1999; Simon et al., 2010; Bulua et al., 2011) . Bulua et al. (2011) found higher baseline levels of mtROS in monocytes and neutrophils from TRAPS patients and in mouse embryonic fibroblasts (MEFs) engineered to express hetero zygous TRAPSassociated TNFR1 mu tations. The enhancement of ROS levels in the mutant MEFs correlated with an increase in the levels of active JNK and p38, a finding consistent with previous research linking persistent MAPK acti vation to manifestation of the TRAPS phenotype (Simon et al., 2010) . Inhibi tion of mtROS production inhibited MAPK activation and production of IL6 and TNF in cells from TRAPS patients (Bulua et al., 2011) , a finding consistent with a previous study showing that ROS can inactivate MAPK phos phatases (Kamata et al., 2005) . Thus, mitochondria are the cellular source of High levels of reactive oxygen species (ROS) are observed in chronic human diseases such as neurodegeneration, Crohn's disease, and cancer. In addition to the presence of oxidative stress, these diseases are also characterized by deregulated inflammatory responses, including but not limited to proinflammatory cytokine production. New work exploring the mechanisms linking ROS and inflammation find that ROS derived from mitochondria act as signaltransducing molecules that provoke the up-regulation of inflammatory cytokine subsets via distinct molecular pathways. lacking NLRP3, caspase1, or IL1R produce normal levels of TNF and IL6 after LPS stimulation (Bulua et al., 2011) . These observations confirm that neither mtROS production nor the signals transduced by mtROS depend on activation of the inflammasome. In a critical mechanistic divergence, two recent studies (Nakahira et al., 2011; Zhou et al., 2011) identify an inflammasomedependent role for mtROS (Fig. 1) .
Pharmacological interventions, such as IL1 antagonists, which are used to treat cryopyrinopathies caused by per turbed inflammasome activation, have limited efficacy for the treatment of TRAPS. Although it is anticipated that mechanisms of reducing mtROS levels may be of therapeutic utility for TRAPS, it remains to be determined how mtROS levels themselves are modu lated. However, some insight is provided by the observation that macrophages the excessive ROS in TRAPS, and a delicate equilibrium between MAP ki nase and phosphatase activity defines a rheostat regulated primarily by the levels of mtROS, which in turn enables an inflammatory response to proceed in a timely and effective fashion. Notably, LPSinduced IL6 production was re duced even in healthy cells treated with mtROS inhibitors, indicating that this signaling cascade is relevant to the induc tion of a normal inflammatory response. Putative mechanisms of ROS-dependent proinflammatory cytokine production in normal, healthy cells. During inflammasomeindependent proinflammatory cytokine production (left), mtROS modulates the equilibrium between positive and negative regulators, which results in an increase in the rate of transcription of cytokines such as IL-6. Several steps in this pathway require further investigation. Specifically, how does activation of TLR4 by LPS result in an increase in ROS production from an individual mitochondrion (A), and how does mtROS inhibit negative regulators (e.g., MAPK phosphatases) of cytokine gene transcription (B)? Inflammasome-dependent proinflammatory cytokine production (right) requires inhibition of autophagy and mitophagy to increase the net amount of mtROS within the cell. The mechanism of this inhibition is unknown (C). Once mtROS accumulates, it activates the NLRP3 inflammasome, but the mechanism of this activation remains undefined (D). Once activated, the NLRP3 inflammasome undergoes a conformational change and assembles into a homooligomeric complex (one subunit is depicted) that catalyzes the activation of pro-caspase-1. In the case of IL-, the active p10-p20 caspase-1 heterodimer cleaves pro-IL-1 to produce a mature form that is subsequently exported from the cell. AP-1, activator protein 1; ASC, apoptosis-associated speck-like protein; CARD, caspase recruitment domain; DAMP, damage-associated molecular patterns; IRF, interferon response factor; LRR, leucine-rich repeat; PAMP, pathogen-associated molecular patterns; PYD, pyrin domain.
Minireview response? The cellular source of physio logically relevant ROS is also stimulus dependent, as inflammatory signaling downstream of TLR ligation is depen dent on mtROS, whereas crystalline particles such as asbestos and silica re quire both NADPH oxidase and mtROS (Dostert et al., 2008; Nakahira et al., 2011; Zhou et al., 2011) . This under scores the importance of defining the physiologically relevant amount and source of ROS for each class of stimuli.
Further experiments will illuminate whether mtROS impacts other proin flammatory transcriptional networks, even though it does not modulate IRF3 dependent induction of IFN (Bulua et al., 2011) . Consequently, elucidating how ROS signaling acquires specificity for any given transcriptional network is of critical importance. Because of the highly reactive nature of ROS, its signal transduction properties are likely to in clude direct chemical modification of its targets and/or catalysis of enzymatic reactions (e.g., H 2 O 2 ). Indeed, the redox regulator superoxide (SOD1) modi fies the redoxsensitive cysteines of caspase1 to modulate its activation (Meissner et al., 2008) . NLRP3 and ASC relocalize to the mitochondria after in flammasome activation (Zhou et al., 2011) , but whether this relocalization facilitates such modifications has yet to be demonstrated and is much antici pated. Another important issue is whether mtROS, or ROS in general, influences the activation of other in flammasomes such as IPAF/NLRC4 or AIM2 inflammasomes. The observa tion that macrophages lacking the IPAF/NLRC4 inflammasome respond normally to artificial induction of ROS and that mtROS production is dispens able for activation of IPAF and AIM2 inflammasomes (Zhou et al., 2011) ar gues against this and raises the question of how specificity for the NLRP3 inflammasome is acquired. Answers to such challenging questions will provide further refinement of the model of ROSdependent proinflammatory cyto kine production, as well as information necessary for the development of novel therapeutic interventions for ROS driven human diseases. perturbation of basal levels of auto phagy had a profound impact on the in tegrity of the mitochondria, as Beclin or LC3deficient macrophages gener ated more mitochondrial superoxide anion radical (O 2  ) in the absence of stimulation. Thus, autophagy regulates baseline mtROS production from indi vidual mitochondria by a yet to be identified mechanism.
The release of mitochondrial DNA (mtDNA) in to the cytosol after treatment of BMDMs with LPS and ATP potentiated caspase1 activation (Nakahira et al., 2011) . Thus, mtDNA is an additional secondary messenger that acts as a surrogate marker of mito chondrial dysfunction and also acti vates caspase1, presumably to amplify the inflammatory response. This am plification loop depends on NLRP3, as NLRP3 deficiency suppressed the release of mtDNA after LPS and ATP stimulation.
Collectively, these two investigations clearly established that in normal healthy cells the process of mitophagy is a critical negative regulator of inflam masome activation. This implies that ac tive inhibition of autophagy is required for proinflammatory signaling to pro ceed, for damaged mitochondria to ac cumulate, for intracellular mtROS to increase, for mtDNA release, and for the NLRP3 inflammasome to be acti vated. Consequently, a pressing ques tion is, how do NLRP3dependent stimuli inhibit autophagy?
The intimate relationship between mtROS production and proinflamma tory cytokine activation is now well established. The fact that different cyto kines are subjected to distinct regula tory events, simplistically defined as either transcriptional or posttranslational, suggests that the generality of any given mechanism is likely to be limited. The distinct temporal regulation of IL1 (early response) and TNF and IL6 (late response) also suggests that different cytokines will be influenced in distinct ways by the production of mtROS. For example, are MAPK phosphatases only inhibited in the presence of higher levels of mtROS that presumably accu mulate at later stages of an inflammatory
The inflammasome does not regu late transcription directly, but rather is responsible for the activation of caspase1, an enzyme responsible for the proteo lytic maturation of IL1 and IL18. Since the initial identification of in flammasomes, much interest has been given to identifying the initiating events that lead to the assembly of these multi protein scaffolds. The multiplicity and apparent divergent nature of NLRP3 dependent stimuli have identified this particular inflammasome as a focus of investigation. Models posited for the ac tivation of the NLRP3 inflammasome include direct interaction with cognate ligand, and conformational alteration induced by secondary messengers or alterations in the intracellular milieu resulting from lysosomal rupture (Latz, 2010) . Consistent with a secondary mes senger model, Zhou et al. (2011) and Nakahira et al. (2011) demonstrate that after an inflammatory stimulus, the ac cumulation of damaged mitochondria precipitates an increase in mtROS pro duction, which in turn enhances in flammasome activation.
Autophagy is the process of "self digestion" that occurs by delivery of selfcomponents to the lysosomal ma chinery. Mitophagy is a specialized form of autophagy that refers to the specific catabolism of mitochondria. Pharmacological inhibition of auto phagy by treatment of macrophages with 3methyladenine resulted in the accumulation of damaged mitochondria and an increase in the net amount of mtROS (Zhou et al., 2011) . IL1 se cretion induced by mtROS elevation was abolished in Nlrp3 / and Asc / cells, thus confirming that the NLRP3 inflammasome is activated in a ROS dependent manner. In bone marrow derived macrophages (BMDMs), genetic deletion of the autophagyrelated pro tein LC3B, which prevents the forma tion and maturation of autophagosomes, also enhanced caspase1 activation and production of IL1 and IL18 in re sponse to the inflammasomedependent stimuli LPS and ATP (Nakahira et al., 2011) . Similar results were observed after deletion of the critical upstream regu lator of autophagy, Beclin 1. In addition,
